Yubo International Biotech Ltd (YBGJ): Gross Profit

Annual figures by period end, from SEC filings.

$8.2K
Year ended 2025-12-31
$8.2K
Trailing 12 months to 2026-06-30
-46.3%
3-year compound annual growth
-63.4%
5-year compound annual growth
$1.24M2020-12-31: $1.24M2021-12-31: $820.6K2022-12-31: $52.7K2023-12-31: $419.2K2024-12-31: $2.6K2025-12-31: $8.2K$8.2K
2020-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$8.2K+208.3%2026-03-31, From 2025-01-01
2024-12-31$2.6K-99.4%2026-03-31, From 2024-01-01
2023-12-31$419.2K+696.1%2025-03-31, From 2023-01-01
2022-12-31$52.7K-93.6%2024-04-12, From 2022-01-01
2021-12-31$820.6K-33.8%2023-04-14, From 2021-01-01
2020-12-31$1.24Mn/a2022-04-15, From 2020-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Yubo International Biotech Ltd (YBGJ)2025-12-31$8.2K+208.3%
Nexalin Technology, Inc. (NXL)2025-12-31$240.3K+81.8%
Positron Corp (POSC)2025-12-31-$2.11Mn/m
iTonic Holdings Ltd (ITOC)2025-12-31$327.4K-14.1%
Guided Therapeutics Inc (GTHP)2025-12-31$571.0Kn/m
Hongchang International Co., Ltd (HCIL)2024-12-31$181.6K+161.9%
ADM Tronics Unlimited, Inc. (ADMT)2026-03-31$1.36M-2.9%
Neuraxis, Inc (NRXS)2025-12-31$3.01M+29.4%
Nuwellis, Inc. (NUWE)2025-12-31$5.12M-9.7%

Compare YBGJ, NXL, POSC, ITOC side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗